13 Apr 2018 maja Nehočkinski limfom Diffuse large B-cell lymphoma: 10 years’ real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone Diffuse large B-cell lymphoma: 10 years’ real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and Read More
13 Apr 2018 maja Hočkinov limfom, Hronična limfocitna leukemija, Nehočkinski limfom NIH study revises molecular classification for most common type of lymphoma NIH study revises molecular classification for the most common type of lymphoma Subgroups of DLBCL by gene expression (left) defined Read More
14 Dec 2017 maja Nehočkinski limfom Subcutaneous vs intravenous rituximab treatment for patients with diffuse large B-cell lymphoma Subcutaneous vs intravenous rituximab treatment for patients with diffuse large B-cell lymphoma Diffuse large B-cell lymphoma (DLBCL) is a common Read More
16 Oct 2017 maja Nehočkinski limfom Treatment options for double-hit diffuse large B-cell lymphoma Treatment options for double-hit diffuse large B-cell lymphoma This study looked at the best treatment options for patients with double-hit Read More